Response to commentary on: A prospective, randomized, parallel group, double blind, multicenter study to compare the efficacy, safety and immunogenicity of Lupin's ranibizumab with Lucentis in patients with neovascular age-related macular degeneration
-
Published:2023
Issue:3
Volume:71
Page:1054
-
ISSN:0301-4738
-
Container-title:Indian Journal of Ophthalmology
-
language:en
-
Short-container-title:Indian J Ophthalmol
Author:
Shah Chirag,Sonkusare Kishore